Phase II Clinical Trial of Adoptive Cell Therapy for Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Low-Dose Interleukin-2
Cancer Immunology, Immunotherapy - Germany
doi 10.1007/s00262-019-02307-x
Full Text
Open PDFAbstract
Available in full text
Date
February 11, 2019
Authors
Publisher
Springer Science and Business Media LLC